In the likely repeal of the Affordable Care Act, these health-care stocks should perform well, according to some analysts.
A potent greenback is bad news for companies that sell goods and services abroad.
The "Fast Money" traders share their final trades of the day, including JetBlue, CME Group and more.
Some of the names on the move ahead of the open.
These are the stocks posting the largest moves after the bell on Wednesday, including Twitter, Taser International, Shake Shack and more.
RBC Capital Markets on Tuesday released a playbook for clients on the market's expected short-term reaction to the U.S. presidential election.
Zimmer Biomet was dragging down the S&P Health Care sector Monday morning after cutting its sales guidance for the year.
CNBC's Meg Tirrell reports on the best biotech performers year-to-date. Sam Isaly, OrbiMed Advisors managing partner, shares his take on the biotech sector, including his bargain stock picks.
It is currently the only sector in the S&P 500 that is negative year to date.
Stocks that would do well in the event of a GOP presidential victory are no longer lagging the Clinton stocks as much as they had been.
If you think more record highs are on the horizon for the Nasdaq, Deirdre Bosa breaks down the best historical ways to play it.
Using Kensho, we screened for the best trades if the Nasdaq index continues to climb.
CNBC's Meg Tirrell reports the latest earnings results for AstraZeneca, Bristol-Myers and Celgene.
Jim Cramer highlights one group that was a clear winner of the first half of 2016.
Finding stock picks in the market rally, with Mariann Montagne, Gradient Investments senior investment analyst, and John Canally, LPL Financial investment strategist and economist.
"Power Lunch" hosts Melissa Lee and Brian Sullivan look at 5 stocks with analyst recommendations, including Alexion and Manpower.
What are the 5 stocks that Wall Street is most bullish on? Eddy Elfenbein of “Crossing Wall Street” blog and Craig Johnson of Piper Jaffray discuss if they’re worth a look with Brian Sullivan.
Shares of Alexion fell nearly 12 percent Monday after the pharmaceutical company said it missed its goal in a late-stage trial of the drug Solaris.
U.S. stocks closed mixed Tuesday, with health care leading decliners and energy leading as oil settled above $50 a barrel for the first time since July.
CNBC's Meg Tirrell looks at some pharma and biotech stocks that are making news today.